About Universitair Ziekenhuis Antwerpen
Het Universitair Ziekenhuis Antwerpen is het universitair ziekenhuis van de Universiteit Antwerpen.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
European Organisation for Research and Treatment of Cancer - EORTC
86
Hoffmann-La Roche
42
Janssen Research & Development, LLC
19
Amgen
18
Boehringer Ingelheim
14
Pfizer
12
Celgene
11
Universitaire Ziekenhuizen KU Leuven
11
Gilead Sciences
10
Bayer
9
Eli Lilly and Company
9
Clinical Trials at Universitair Ziekenhuis Antwerpen
During the past decade, Universitair Ziekenhuis Antwerpen conducted 321 clinical trials. In the 10-year time frame, 321 clinical trials started and 112 clinical trials were completed, i.e. on
average, 34.9% percent of trials that started reached the finish line to date. In the past 5 years, 119 clinical trials started and 66 clinical trials were completed. i.e. 55.5%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Strontium Compared With Radiation Therapy in Treating Patients With Hormone-Refractory Prostate Cancer With Painful Bone Metastases
1992-10-01
Completed
204
Combination Chemotherapy and Surgery With or Without G-CSF in Treating Patients With Osteosarcoma
1993-08-01
Completed
214
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia
1993-11-01
Unknown status
1,520
Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer
1994-12-01
Completed
640
Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma
1995-02-01
2012-06-01
Completed
350
Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma
1995-06-01
Completed
90
Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia
1995-08-01
Completed
392
Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia
1995-10-01
Unknown status
750
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Universitair Ziekenhuis Antwerpen" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 86 trials, followed by "Hoffmann-La Roche" with 42 trials
sponsored, "Janssen Research & Development, LLC" with 19 trials sponsored, "Amgen" with 18 trials sponsored and "Boehringer Ingelheim"
with 18 trials sponsored. Other sponsors include 356 different institutions and
companies that sponsored additional 188 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Universitair Ziekenhuis Antwerpen"
#1 collaborator was "Universiteit Antwerpen" with 10 trials as a collaborator, "University Hospital, Antwerp" with 9 trials as a collaborator, "Merck Sharp & Dohme LLC" with 8 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 7 trials as a collaborator and "AstraZeneca" with 6 trials as a collaborator. Other collaborators include 297 different institutions and companies that were
collaborators in the rest 232 trials.
Clinical Trials Conditions at Universitair Ziekenhuis Antwerpen
According to Clinical.Site data, the most researched conditions in "Universitair Ziekenhuis Antwerpen" are
"Breast Cancer" (23 trials), "Multiple Myeloma" (16 trials), "Leukemia" (11 trials), "Crohn Disease" (10 trials) and "Endometrial Cancer" (9 trials). Many other conditions were trialed in "Universitair Ziekenhuis Antwerpen" in a lesser frequency.
Clinical Trials Intervention Types at Universitair Ziekenhuis Antwerpen
Most popular intervention types in "Universitair Ziekenhuis Antwerpen" are "Drug" (410 trials), "Biological" (59 trials), "Other" (44 trials), "Device" (42 trials) and "Procedure" (42 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (97 trials), "Paclitaxel" (21 trials), "cisplatin" (21 trials), "radiation therapy" (19 trials) and "Docetaxel" (15 trials). Other intervention names were less common.
Clinical Trials Genders at Universitair Ziekenhuis Antwerpen
The vast majority of trials in "Universitair Ziekenhuis Antwerpen" are
483 trials for "All" genders, 45 trials for "Female" genders and 12 trials for "Male" genders.
Clinical Trials Status at Universitair Ziekenhuis Antwerpen
Currently, there are 199 active trials in "Universitair Ziekenhuis Antwerpen".
1 are not yet recruiting,
117 are recruiting,
79 are Active, not recruiting,
and 2 are Enrolling by invitation.
In total, there were 258 completed trials in Universitair Ziekenhuis Antwerpen,
3 suspended trials,
and 43 terminated clinical trials to date.
Out of the total trials that were conducted in Universitair Ziekenhuis Antwerpen, 69 "Phase 1"
clinical trials were conducted, 177 "Phase 2" clinical
trials and 205 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 18 trials, and there were
also 43 trials that are defined as “Not Applicable".
Departments of Universitair Ziekenhuis Antwerpen
Universitair Ziekenhuis Antwerpen has several departments that took part in Clinical trials: "Universitair Ziekenhuis Antwerpen Oncologie" - 4 trials, "UZ AntwerpenDienst nefrologie" - 3 trials, "Universitair Ziekenhuis Antwerpen, Gastro-Enterologie," - 3 trials, "Dienst Cardiale Revalidatie, Cardiologie, Universitair Ziekenhuis Antwerpen" - 2 trials
Departments List